CVE-2023-38958 — MEDIUM (5.3)

Vulnerability Description

An access control issue in ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to arbitrarily close and open the doors managed by the platform remotely via sending a crafted web request.

CVSS Score

5.3

MEDIUM

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:L/A:N

Attack Vector

NETWORK

Attack Complexity

LOW

Privileges Required

NONE

User Interaction

NONE

Scope

UNCHANGED

Confidentiality

NONE

Integrity

LOW

Availability

NONE

Affected Products

Vendor	Product	Versions
Zkteco	Bioaccess Ivs	3.3.1

Related Weaknesses (CWE)

CWE-863

References

http://zkteco.comProduct
https://claroty.com/team82/disclosure-dashboard/cve-2023-38958Third Party Advisory
http://zkteco.comProduct
https://claroty.com/team82/disclosure-dashboard/cve-2023-38958Third Party Advisory

FAQ

What is CVE-2023-38958?

CVE-2023-38958 is a vulnerability with a CVSS score of 5.3 (MEDIUM). An access control issue in ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to arbitrarily close and open the doors managed by the platform remotely via sending a crafted web request.

How severe is CVE-2023-38958?

CVE-2023-38958 has been rated MEDIUM with a CVSS base score of 5.3/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2023-38958?

Check the references section above for vendor advisories and patch information. Affected products include: Zkteco Bioaccess Ivs.